Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeXSAT01000486

Price Information

+/-(0.24)
%-5.33
Latest4.26
High4.66
Low4.13
Volume384,232
Turnover (SEK)1,652,163
Market Cap (MSEK)228

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:29 PMAVANON4.262,743
5:29 PMNONNON4.26160
5:29 PMNONNON4.26130
5:29 PMAVAAVA4.263,865
5:21 PMNONAVA4.2914
5:21 PMNONAVA4.2911
5:19 PMAVAAVA4.29470
5:15 PMAVAAVA4.292,040
5:13 PMNONAVA4.29500
5:08 PMNONAVA4.29900

Scheduled Reports

DateReport
2017-08-23Bokslutskommuniké för 2016/2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se